-
DE
The incretin effect describes the enhanced insulin secretion triggered by oral glucose intake compared to intravenous glucose. It plays a key role in blood sugar regulation.
Add as Preferred SourceThe incretin effect describes the enhanced insulin secretion triggered by oral glucose intake compared to intravenous glucose. It plays a key role in blood sugar regulation.
The incretin effect refers to the phenomenon whereby oral ingestion of glucose triggers a significantly greater release of insulin from the pancreas compared to the same amount of glucose administered intravenously. This difference is mediated by specialized gut hormones known as incretins. In healthy individuals, the incretin effect accounts for approximately 50–70 % of the total postprandial insulin response. In people with type 2 diabetes, this effect is markedly reduced, contributing to elevated blood sugar levels after meals.
Two hormones are primarily responsible for the incretin effect:
Both hormones are rapidly secreted into the bloodstream after food intake and are quickly broken down by the enzyme DPP-4 (Dipeptidyl Peptidase-4), limiting their biological activity to just a few minutes.
When carbohydrates, fats, and proteins reach the small intestine, specialized enteroendocrine cells release GLP-1 and GIP into the bloodstream. These hormones travel to the pancreas and bind to specific receptors on the beta cells of the islets of Langerhans, triggering a glucose-dependent increase in insulin secretion. Because this stimulation only occurs when blood glucose is elevated, the risk of hypoglycemia (low blood sugar) under normal physiological conditions remains low.
In addition, GLP-1 inhibits the alpha cells of the pancreas, suppressing the release of glucagon, a hormone that raises blood glucose. This dual mechanism plays a crucial role in postprandial blood glucose control.
In patients with type 2 diabetes, the incretin effect is reduced to approximately 20 % of normal. Contributing factors include:
This impairment results in an insufficient insulin response to meals and contributes to postprandial hyperglycemia (elevated blood sugar after eating).
Understanding the incretin effect has led to the development of important diabetes medications:
Both drug classes are now among the cornerstone therapies in modern diabetes management.
The incretin effect is also of interest in other medical areas. Following bariatric surgery (e.g., Roux-en-Y gastric bypass), the incretin effect is markedly enhanced, which contributes to rapid improvement in glycemic control even before significant weight loss occurs. Furthermore, the roles of GLP-1 in appetite regulation, cardiovascular health, and neurological function are subjects of active research.